W
HAE icon

Wealthfront’s Haemonetics HAE Stock Holding History

Wealthfront’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-223
Closed -$7K – 595
2015
Q3 		$7K Buy
223
+30
+16% +$1.13K ﹤0.01% 1043
2015
Q2 		$8K Buy
193
+162
+523% +$6.83K ﹤0.01% 906
2015
Q1 		$1K Buy
31
+30
+3,000% +$1.25K ﹤0.01% 1099
2014
Q4 		$0 Buy
+1
New +$37 ﹤0.01% 796

Other funds holding HAE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.3B AUM 29.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Wealthfront's HAE Position: Q4 2015 in Review

Wealthfront sold out of Haemonetics (HAE) in Q4 2015, closing a stake of 223 shares — an estimated $7K sold.

Wealthfront first reported a position in HAE in Q4 2014 and held it in 4 quarters. The position peaked at $8K in Q2 2015. 164 funds tracked by Wall St. Rank hold HAE as of Q4 2015.

  • Wealthfront reported no remaining Haemonetics position as of Q4 2015 after selling out during the quarter.
  • Wealthfront sold 223 Haemonetics shares in Q4 2015, an estimated $7K.
  • Wealthfront first reported a position in Haemonetics in Q4 2014 and held it in 4 quarters.
  • Wealthfront's Haemonetics position peaked at $8K in Q2 2015.
  • 164 funds tracked by Wall St. Rank held Haemonetics as of Q4 2015.

Based on Wealthfront's 13F filing for Q4 2015, filed 17 Feb 2016.